SUMMARY
Vishu Avutu, M.D., investigates strategies to improve outcomes for adolescents and young adults with cancer, with a particular focus on soft tissue sarcomas and bone tumors. He integrates early-phase clinical trials, translational studies and patient-centered outcomes research to better meet the needs of patients and provide options in situations where treatments are limited. His goal is to improve outcomes for patients with sarcoma. Dr. Avutu specifically evaluates targeted therapies and rational drug combinations in sarcoma, with a special interest in DNA damage response pathways and cell cycle regulation.
Dr. Avutu's research also addresses clinical trial access, variations between pediatric and adult oncology care, and health-related quality of life for adolescents and young adults with cancer. He develops and validates patient-reported outcome measures tailored to this population and studies challenges to clinical trial participation. These programs connect therapeutic development with the measurement of patients' experiences and needs. Dr. Avutu's work also supports research designed to improve disease outcomes and the delivery of age-appropriate cancer care.
Focus areas
- Sarcoma precision therapeutics. Dr. Avutu conducts early-phase and multicenter clinical trials of new targeted therapies and combination strategies for soft tissue sarcomas and bone tumors. He studies DNA damage response and cell cycle targets, including inhibition of the WEE1 kinase that regulates the G2-M cell cycle checkpoint. Through his research, Dr. Avutu identifies biologically informed approaches for sarcoma subtypes with limited effective treatment options.
- Adolescent and young adult outcomes. Dr. Avutu develops patient-reported outcome measures for adolescents and young adults with cancer. He leads work to define and validate measures that capture this population's distinctive psychosocial, functional and health-related quality-of-life concerns. Dr. Avutu incorporates these outcomes into clinical care and future trials.
- Clinical trial access. Dr. Avutu studies gaps affecting enrollment of adolescents and young adults in cancer clinical trials and ways to facilitate enrollment. His work examines differences across pediatric and adult oncology settings. Dr. Avutu also evaluates strategies to improve access, communication and collaboration across cooperative research groups.
- Adolescent and young adult care delivery. Dr. Avutu studies how care models can better address the clinical and psychosocial needs of adolescents and young adults with cancer. His work includes developing integrated oncology programs and assessment approaches. These methods reduce fragmentation between pediatric and adult care and improve the delivery of age-appropriate supportive services.
Significance to patient care
Adolescents and young adults with cancer can face differences in specialized care and challenges joining clinical trials. Their health needs may not be fully met by programs designed for younger children or older adults.
Dr. Avutu's research seeks to improve this experience in two ways. He tests new treatments for soft-tissue sarcomas and bone tumors. He also develops better ways to measure what matters to patients.
Dr. Avutu's work may help medical teams choose more effective treatments and improve access to research studies. He also works to provide cancer care that better reflects patients' medical and quality-of-life needs.
Professional highlights
- Connective Tissue Oncology Society:
- Chair, Young Investigator Advisory Board, 2025-present.
- Founder, Young Investigator Advisory Board, 2025-present.
- American Society of Clinical Oncology:
- Co-chair, Early Onset and Adolescent and Young Adult Community of Practice, 2024-present.
- Young Investigator Award, Conquer Cancer, 2020.
- Principal investigator, Patient and Family Centered Care Grant Initiative, Memorial Sloan Kettering Cancer Center, 2019-2023.
- Education Innovation Grant, Department of Medicine, Brigham and Women's Hospital, 2016-2018.
- Innovation Grant, Alliance for Academic Internal Medicine, 2016-2018.
- Allen C. Crocker Advocacy Fellowship, Boston Children's Hospital, 2016.
- L. Randol Barker — Joseph Cofrancesco Jr. — David E. Kern Award, Johns Hopkins Medicine, 2016.